PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-mouse TCR γ/δ, 25 μg
PE/Cy7 anti-mouse TER-119/Erythroid Cells, 100 μg
PE/Cy7 anti-mouse TER-119/Erythroid Cells, 25 μg
PE/Cy7 anti-mouse TIGIT (Vstm3), 100 μg
PE/Cy7 anti-mouse TIGIT (Vstm3), 25 μg
PE/Cy7 anti-mouse Tim-4, 100 μg
PE/Cy7 anti-mouse Tim-4, 25 μg
PE/Cy7 anti-mouse TLR4 (CD284)/MD2 Complex), 100 μg
PE/Cy7 anti-mouse TLR4 (CD284)/MD2 Complex), 25 μg
PE/Cy7 anti-mouse/human CD11b, 100 μg
PE/Cy7 anti-mouse/human CD11b, 25 μg
PE/Cy7 anti-mouse/human CD324 (E-Cadherin), 100 μg
PE/Cy7 anti-mouse/human CD324 (E-Cadherin), 25 μg
PE/Cy7 anti-mouse/human CD44, 100 μg
PE/Cy7 anti-mouse/human CD44, 25 μg
PE/Cy7 anti-mouse/human CD45R/B220, 100 μg